Healthcare and Life Science
Evonetix announces agreement for revolutionary Gene Synthesis Platform with Analog Devices
Cambridge, UK, 06 December 2023 – EVONETIX LTD (‘Evonetix’), the company developing semiconductor scale technology to improve access to gene synthesis, announces the signing of a joint development agreement and commercial supply agreement with Analog Devices, Inc. (ADI), a global semico...
The Paradigm Shift: Navigating the emergence of value-based contracts for future gene therapies
Value-based contracting (VBC) has been difficult to execute in the pharmaceutical arena, especially in the gene therapy space. This has been driven by several factors, including the lack of long-term data, the imbalance of upside and downside risk between manufacturers and payers, and d...
Making AI work for you: 6 tips to future-proof your career
Career Ambitions writes...How do you feel about the rapid development in AI? Fascinated? Terrified? Maybe a little bit of both? Whilst the possibilities it offers are undoubtedly exciting, the alarming predictions in the media about how AI could kill certain jobs, has left many of us f...
Inward investment service attracts health tech pioneer to set up its global HQ in Cambridgeshire
An Australian-founded health tech company opened its global HQ in Cambridgeshire due to the support provided by the Combined Authority’s dedicated inward investment service branded as Locate Cambridge. ...
CN Bio PhysioMimix Organ-on-a-Chip data supports Inipharm’s INI-822 for metabolic liver disease treatment now in clinical testing
PhysioMimix NASH assay used to provide human-relevant data on compound efficacy for Inipharm’s lead candidate, INI-822 Submission represents first example of an OOC provider’s data supporting clinical progression of a drug for metabolic, fibrotic liver disease Cambridge, UK - ...
Arecor signs co-development and exclusive licence option agreement with leading global medical products company for in-house speciality hospital product
Arecor-developed, Arestat™-enabled product is potentially first ready-to-dilute liquid formulation of a high-value oncology therapy ...
Double your donation with the Big Give
Tom’s Trust is joining forces with the Big Give again this year to double supporters’ donations and launch its Christmas campaign for 2023. The campaign, ‘Donate Your Last Hour’, encourages the charity’s supporters to donate their last hour of wages in 2023, which will then be...
Matrix Bio, a Cambridge based biotech startup wins the o2h tech kickstarter 2.0 competition
Cambridge, UK: We are thrilled to announce the first winner of the tech Kickstarter 2.0 Competition – Matrix Bio! Based in Cambridge, Matrix Bio is an early-stage tech bio startup developing disruptive digital platforms to transform how researchers design and optimize hydrogels. ...
Arecor continues collaboration with Lilly
Development of an enhanced formulation of Lilly proprietary product using Arecor’s formulation technology platform Arestat™ ...
Celebrating our Centres – London UCLH
This week we spoke to the team in London at BioResource Centre UCLH about what they’ve been working on and their priorities ahead. Learn about PPIE activity, what various members of the team have to say, how volunteer data is being used, and plans to engage underrepresented groups in th...